Virata 90mg Tablet

Virata 90mg Tablet contains the active ingredient ticagrelor, which belongs to a class of medications known as antiplatelet drugs. It is primarily used in the prevention of blood clots in patients with acute coronary syndrome (ACS), including unstable angina or myocardial infarction (heart attack) with or without ST-segment elevation.

Uses:

Virata 90mg Tablet is prescribed for the following purposes:

1. Prevention of blood clots in patients with acute coronary syndrome (ACS), including:
   • Unstable angina (chest pain at rest or with minimal exertion)
   • Non-ST-segment elevation myocardial infarction (NSTEMI)
   • ST-segment elevation myocardial infarction (STEMI)
2. Reduction of the risk of cardiovascular events, including heart attack, stroke, and cardiovascular death, in patients with a history of ACS or a history of myocardial infarction.

Ticagrelor works by inhibiting platelet aggregation, which is a crucial step in the formation of blood clots. By preventing platelets from sticking together, it reduces the risk of thrombotic events such as heart attack and stroke.

Dosage:

The usual dosage of Virata 90mg Tablet is one tablet (90mg) taken orally twice daily, preferably with meals. It is important to follow the dosage instructions provided by the healthcare provider.

Precautions:

• Virata 90mg Tablet should be used with caution in patients with a history of bleeding disorders or gastrointestinal ulcers.
• Patients should inform their healthcare provider about all other medications, including over-the-counter drugs and supplements, as some medications may interact with ticagrelor.
• It is essential to avoid sudden discontinuation of ticagrelor therapy without consulting a healthcare professional, as it may increase the risk of cardiovascular events.
• Ticagrelor may increase the risk of bleeding, so patients should promptly report any signs of bleeding, including unusual bruising, bleeding gums, or blood in the stool or urine.

When Not to Use:

Virata 90mg Tablet should not be used in the following conditions:

• Hypersensitivity to ticagrelor or any other components of the medication.
• Active pathological bleeding, such as gastrointestinal bleeding or intracranial hemorrhage.
• Severe hepatic impairment.

FAQs:

1. How long should Virata 90mg Tablet be taken after a heart attack?
   • The duration of ticagrelor therapy after a heart attack (myocardial infarction) may vary depending on individual patient factors and the healthcare provider’s recommendations. In general, treatment with antiplatelet therapy such as ticagrelor is typically continued for at least 12 months following a heart attack.
2. Can Virata 90mg Tablet be crushed or split?
   • Virata 90mg Tablet should be swallowed whole with water and should not be crushed, chewed, or split. Breaking the tablet may increase the risk of inadequate dosing and decrease the efficacy of the medication.
3. Is Virata 90mg Tablet a blood thinner?
   • Ticagrelor is not a blood thinner in the traditional sense but rather an antiplatelet medication. It works by inhibiting platelet aggregation, which is a crucial step in the formation of blood clots. While it reduces the risk of blood clots, it does not significantly affect the coagulation factors involved in blood clotting.
4. Can Virata 90mg Tablet be used during pregnancy or breastfeeding?
   • Ticagrelor is not recommended for use during pregnancy unless the potential benefits outweigh the risks. It is also not known whether ticagrelor is excreted in human breast milk, so breastfeeding while taking this medication is not recommended.
5. What should I do if I miss a dose of Virata 90mg Tablet?
   • If a dose of Virata 90mg Tablet is missed, it should be taken as soon as possible unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed. Double doses should not be taken to make up for missed doses.